Archives
Preprint Study Suggests Children May Be as Infectious as Adults
1 May, 2020 | 03:36h | UTC
Small Observational Study Suggests Prophylactic LMWH Can Prevent COVID‐19 Disseminated Intravascular Coagulopathy
1 May, 2020 | 03:26h | UTCCOVID‐19 Coagulopathy in Caucasian patients – British Journal of Haematology
Treatment Considerations for COVID-19: A Critical Review of the Evidence
1 May, 2020 | 03:20h | UTC
New Model to Track Covid-19 Spread
1 May, 2020 | 03:29h | UTCPopulation flow drives spatio-temporal distribution of COVID-19 in China – Nature
Commentary: Researchers devise new model to track COVID-19’s spread – Yale News
[Abstract Only] Cohort Study: Effect of Hydroxychloroquine and Azithromycin on the QT Interval in Patients with Covid-19
1 May, 2020 | 03:10h | UTCThe Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection – Circulation: Arrhythmia and Electrophysiology (link to abstract – $ for full-text)
COVID-19 and the Cardiovascular System: Implications for Risk Assessment, Diagnosis, and Treatment Options
1 May, 2020 | 03:18h | UTCRelated Guidelines: COVID-19 rapid guideline: acute myocardial injury – National Institute for Health and Care Excellence AND ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic – European Society of Cardiology AND Management of Acute Myocardial Infarction During the COVID-19 Pandemic – Journal of the American Academy of Cardiology
Perspective: Urging Caution on Remdesivir
1 May, 2020 | 03:07h | UTCUrging Caution On Remdesivir – Forbes
Related: About Remdesivir and About “Game-Changers” – Science Translational Medicine AND Conflicting Remdesivir Trial Results Released; Experts Urge More Research – Health Policy Watch AND Is remdesivir a miracle drug to cure coronavirus? Don’t get your hopes up yet – The Conversation AND PulmCrit- First placebo-controlled RCT on remdesivir for COVID-19 – PulmCrit AND Remdesivir: the antiviral drug is being touted as a possible coronavirus treatment – but will it work? – The Guardian
“While I have enormous respect for the Institutes and their leaders, releasing the preliminary news without sharing the data behind it is highly irresponsible.”
Review: Neurologic Comorbidities and Complications in Patients Hospitalized for COVID-19
1 May, 2020 | 03:03h | UTCRelated Studies: Neurologic Features in Severe SARS-CoV-2 Infection – New England Journal of Medicine AND Neurologic Manifestations Common in Hospitalized Patients with Covid-19 (study and commentaries)
COVID-19: ICU Delirium Management During SARS-CoV-2 Pandemic
1 May, 2020 | 02:54h | UTCCOVID-19: ICU delirium management during SARS-CoV-2 pandemic – Critical Care
ACR Guidance for the Management of Patients with Rheumatic Disease During the COVID‐19 Pandemic
1 May, 2020 | 02:42h | UTC
We Need to Flatten the ‘Other’ Coronavirus Curve, Our Looming Mental Health Crisis
1 May, 2020 | 02:45h | UTCRelated: Health Care Workers Seek to Flatten COVID-19’s ‘Second Curve’—Their Rising Mental Anguish
Clinical Determinants for Fatality of 44,672 Patients with COVID-19
1 May, 2020 | 02:48h | UTCClinical determinants for fatality of 44,672 patients with COVID-19 – Critical Care
AAN Recommendations for Closure of Patent Foramen Ovale in Secondary Stroke Prevention
1 May, 2020 | 02:34h | UTCNews Release: AAN updates recommendation on closure of common heart defect after stroke – American Academy of Neurology
Systematic Review: No Evidence to Support the Use of Aspirin for the Prevention of Dementia
1 May, 2020 | 02:38h | UTCRelated Randomized Trial: Aspirin Not Beneficial for Reducing the Risk of Dementia, MCI, or Cognitive Decline
Fri May 01 – 10 Stories of The Day!
1 May, 2020 | 03:58h | UTC
1 – Care for Breastfeeding Women – Centers for Disease Control and Prevention
Related: Journal articles on coronavirus with relevance for skin diseases and dermatology – Centre of Evidence Based Dermatology, University of Nottingham AND Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak – Journal of the American Academy of Dermatology
Great atlas with the different cutaneous manifestations of Covid-19.
4 – Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China – Science
6 – Antibody responses to SARS-CoV-2 in patients with COVID-19 – Nature Medicine
Commentary: Expert reaction to antibody response in COVID-19 patients – Science Media Centre
7 – Population flow drives spatio-temporal distribution of COVID-19 in China – Nature
Commentary: Researchers devise new model to track COVID-19’s spread – Yale News
8 – COVID‐19 Coagulopathy in Caucasian patients – British Journal of Haematology
10 – Coronavirus Disease (COVID-19) Updates / 01 May 2020 Edition
01 May 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)
Randomized Trial: Remdesivir Not Beneficial for Adults with Severe COVID-19
30 Apr, 2020 | 04:31h | UTCCommentaries: First randomized trial of remdesivir suggests antiviral drug is not associated with significant clinical benefits, more research needed – The Lancet AND Expert reaction to trial of remdesivir in adults – Science Media Centre
See also: [Not Published Yet] NIH Study Shows Remdesivir Accelerates Recovery from Advanced COVID-19
Related Commentary on Twitter
With all the hype about Remdesivir today @TheLancet has decided to lift the embargo and release this placebo-controlled multicenter study done in China that showed no benefit https://t.co/ZdmKfnWLyw
— Carlos del Rio (@CarlosdelRio7) April 29, 2020
Pooling of Samples for Testing for SARS-CoV-2 in Asymptomatic People
30 Apr, 2020 | 04:25h | UTCPooling of samples for testing for SARS-CoV-2 in asymptomatic people – The Lancet Infectious Diseases AND Commentary: Virologists show that sample pooling can massively increase coronavirus testing capacity – Saarland University
Related Preprint Study: Smart Pooled sample Testing for COVID-19: A Possible Solution for Sparsity of Test Kits – medRxiv AND Commentary: ‘Smart sample pooling’ for COVID-19 could solve test kit shortage problem – News Medical
[Not Published Yet] NIH Study Shows Remdesivir Accelerates Recovery from Advanced COVID-19
30 Apr, 2020 | 04:28h | UTCCommentaries: Hopes rise on coronavirus drug remdesivir – Nature AND The COVID-19 research news rollercoaster is running again: STAT News + Gilead’s remdesivir – HealthNews Review
See also: Randomized Trial: Remdesivir Not Beneficial for Adults with Severe COVID-19
Audio Interview: Loosening Covid-19 Restrictions
30 Apr, 2020 | 04:17h | UTCAudio Interview: Loosening Covid-19 Restrictions – New England Journal of Medicine
Men with COVID-19 Twice More Likely to Die than Women
30 Apr, 2020 | 04:21h | UTCNews Release: COVID-19 study shows that men have over double the death rate of women – Frontiers
Perspective: Covid-19 — A Reminder to Reason
30 Apr, 2020 | 04:15h | UTCCovid-19 — A Reminder to Reason – New England Journal of Medicine
Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy
30 Apr, 2020 | 04:19h | UTC
COVID-19 and Its Implications for Thrombosis and Anticoagulation
30 Apr, 2020 | 04:13h | UTCCOVID-19 and its implications for thrombosis and anticoagulation – Blood
Science Has an Ugly, Complicated Dark Side. And the Coronavirus Is Bringing It Out
30 Apr, 2020 | 04:10h | UTCScience Has an Ugly, Complicated Dark Side. And the Coronavirus Is Bringing It Out – Mother Jones
What Is the Infection-Fatality Rate of COVID-19?
30 Apr, 2020 | 04:04h | UTCWhat Is the Infection-Fatality Rate Of COVID-19? – Medium